Company / Gross Profit
Regenerative Medical Technology Group Inc. Gross Profit History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$2.8M
FY2025
5-year range
$150.1K / $2.8M
FY2021-FY2025
Trend
-0.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +202.3%.
Improved from $2M to $3M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +47.4%
- 5-Year CAGR
- +202.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +202.3%, indicating consistent growth.
- In FY2025, gross profit decreased 0.4% year-over-year.
- Peak gross profit was recorded in FY2024.
- Lowest gross profit in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8M | -0.4% |
| FY2024 | $2.8M | +68.5% |
| FY2023 | $1.7M | +91.1% |
| FY2022 | $877.0K | +484.1% |
| FY2021 | $150.1K | +1249.2% |
| FY2020 | $11.1K | +143.8% |
| FY2019 | -$25.4K | -39.5% |
| FY2018 | -$18.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026